Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Pitts

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of the Indiana State Medical Association|June 1, 1983
Thrombolytic therapy in acute myocardial infarction. Methodist Hospital experienceD E Pitts, R P Valentine, J A Brooks
Indiana Medicine : the Journal of the Indiana State Medical Association|April 1, 1987
Update on thrombolytic therapyk C Stanley, D E Pitts, R P Valentine
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 10, 2002
Immunohistochemical model to predict risk for coronary artery disease and failure in heart transplant patientsC A Labarre, D R Nelson, D E Pitts, et al.
Indiana Medicine : the Journal of the Indiana State Medical Association|November 1, 1989
Post inferior myocardial infarction ventricular septal ruptureJ A Trippi, D E Pitts, J W Fehrenbacher, et al.
The American Journal of Cardiology|February 1, 1985
Intravenous versus intracoronary streptokinase in acute myocardial infarctionR P Valentine, D E Pitts, J A Brooks-Brunn, et al.
The American Journal of Cardiology|November 1, 1986
Effect of thrombolysis (streptokinase) on left ventricular function during acute myocardial infarctionR P Valentine, D E Pitts, J A Brooks-Brunn, et al.
The American Journal of Cardiology|February 17, 2001
Vascular antithrombin and clinical outcome in heart transplant patientsC A Labarrere, R J Torry, D R Nelson, et al.
Indiana Medicine : the Journal of the Indiana State Medical Association|May 1, 1987
Recombinant tissue-type plasminogen activator as a thrombolytic agent in acute myocardial infarctionK L Parr, R P Valentine, D E Pitts, et al.
Circulation|September 27, 2000
Value of serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, posttransplant ischemic events, and cardiac graft failureC A Labarrere, D R Nelson, S J Miller, et al.
Journal of the American College of Cardiology|April 1, 1990
Improved infarct-related arterial patency after high dose, weight-adjusted, rapid infusion of tissue-type plasminogen activator in myocardial infarction: results of a multicenter randomized trial of two dosage regimensR W Smalling, R Schumacher, D Morris, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of the Indiana State Medical Association|June 1, 1983
Thrombolytic therapy in acute myocardial infarction. Methodist Hospital experienceD E Pitts, R P Valentine, J A Brooks
Indiana Medicine : the Journal of the Indiana State Medical Association|April 1, 1987
Update on thrombolytic therapyk C Stanley, D E Pitts, R P Valentine
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 10, 2002
Immunohistochemical model to predict risk for coronary artery disease and failure in heart transplant patientsC A Labarre, D R Nelson, D E Pitts, et al.
Indiana Medicine : the Journal of the Indiana State Medical Association|November 1, 1989
Post inferior myocardial infarction ventricular septal ruptureJ A Trippi, D E Pitts, J W Fehrenbacher, et al.
The American Journal of Cardiology|February 1, 1985
Intravenous versus intracoronary streptokinase in acute myocardial infarctionR P Valentine, D E Pitts, J A Brooks-Brunn, et al.
The American Journal of Cardiology|November 1, 1986
Effect of thrombolysis (streptokinase) on left ventricular function during acute myocardial infarctionR P Valentine, D E Pitts, J A Brooks-Brunn, et al.
The American Journal of Cardiology|February 17, 2001
Vascular antithrombin and clinical outcome in heart transplant patientsC A Labarrere, R J Torry, D R Nelson, et al.
Indiana Medicine : the Journal of the Indiana State Medical Association|May 1, 1987
Recombinant tissue-type plasminogen activator as a thrombolytic agent in acute myocardial infarctionK L Parr, R P Valentine, D E Pitts, et al.
Circulation|September 27, 2000
Value of serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, posttransplant ischemic events, and cardiac graft failureC A Labarrere, D R Nelson, S J Miller, et al.
Journal of the American College of Cardiology|April 1, 1990
Improved infarct-related arterial patency after high dose, weight-adjusted, rapid infusion of tissue-type plasminogen activator in myocardial infarction: results of a multicenter randomized trial of two dosage regimensR W Smalling, R Schumacher, D Morris, et al.
Pageof 2